Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: Improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2-Reference-Cited by-同舟云学术

Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: Improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2

Published:1994-01 Issue:8 Volume:30 Page:1078-1083
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Escudier B,Farace F,Angevin E,Charpentier F,Nitenberg G,Triebel F,Hercend T

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. Observations of the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer;Rosenberg;New Engl J Med,1985

2. Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer;West;New Engl J Med,1987

3. Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2;Mule;Science,1984

4. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo;Mule;J Immunol,1985

5. Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2;Lafreniere;Cancer Res,1985

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of cell therapy for renal cell carcinoma;Molecular Cancer;2024-01-09

2. The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy;Cancers;2023-04-16

3. Immunotherapy in Glioblastoma: A Clinical Perspective;Cancers;2021-07-24

4. The Role of Natural Killer (NK) Cells in Acute Coronary Syndrome: A Comprehensive Review;Biomolecules;2020-11-05

5. Current progress in cancer immunotherapy based on natural killer cells;Cell Biology International;2020-10-08